In The News Posted February 28, 2019 Share Posted February 28, 2019 LOUISVILLE, Ky. and HOUSTON, Feb. 28, 2019 /PRNewswire/ -- NX Prenatal Inc., focused on development of proprietary blood-based, early warning molecular diagnostic tests for adverse pregnancy outcomes, announced today the publication of a peer-reviewed study, "Circulating Microparticle... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.